Makk et al. also studied EZH2 expression in 37 cases of various histological types of adenocarcinoma and observed high expression of EZH2 in 98.14% of various adenocarcinomas and concluded that the robust EZH2 expression is an excellent diagnostic marker capable of differentiating the glandular neoplastic lesions from non-neoplastic lesions of cervix [9]. This evidence concerns the gene EZH2 and adenocarcinoma.